There have been 50 recent insider transactions recorded for Palisade Bio, Inc. (PALI), including 34 buys and 15 sells. Total insider buying was valued at $75.36K and total insider selling at $50.59K.
Notable insiders with recent activity include Finley John David, Jones Mitchell Lawrence, Williams Donald Allen. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — PALI
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-02-12 |
Finley John David |
CEO, CFO |
Informative Sell |
3,896 |
$1.75 |
$6.82K |
27,353 |
| 2026-02-12 |
Jones Mitchell Lawrence |
Chief Medical Officer |
Informative Sell |
1,989 |
$1.75 |
$3.48K |
13,263 |
| 2026-02-11 |
Finley John David |
CEO, CFO |
Option Exercise (Sell) |
13,333 |
- |
- |
26,667 |
| 2026-02-11 |
Jones Mitchell Lawrence |
Chief Medical Officer |
Option Exercise |
8,000 |
- |
- |
15,252 |
| 2026-02-09 |
Finley John David |
CEO, CFO |
RSU Award |
2,011,000 |
- |
- |
2,011,000 |
| 2026-02-09 |
Jones Mitchell Lawrence |
Chief Medical Officer |
RSU Award |
787,000 |
- |
- |
787,000 |
| 2026-01-16 |
Williams Donald Allen |
Director |
Informative Buy |
5,000 |
$1.67 |
$8.36K |
10,728 |
| 2026-01-09 |
Williams Donald Allen |
Director |
Informative Buy |
5,000 |
$1.88 |
$9.4K |
5,728 |
| 2025-10-06 |
Williams Donald Allen |
Director |
RSU Award |
1,538,700 |
- |
- |
1,538,700 |
| 2025-10-06 |
Wei Binxian |
Director |
RSU Award |
510,700 |
- |
- |
510,700 |
| 2025-10-06 |
Finley John David |
CEO, CFO |
RSU Award |
9,179,400 |
- |
- |
9,179,400 |
| 2025-10-06 |
Chuang Emil |
Director |
RSU Award |
510,700 |
- |
- |
510,700 |
| 2025-10-06 |
Jones Mitchell Lawrence |
Chief Medical Officer |
RSU Award |
7,665,800 |
- |
- |
7,665,800 |
| 2025-10-06 |
Williams Donald Allen |
Director |
RSU Award |
182,000 |
- |
- |
182,000 |
| 2025-10-06 |
Wei Binxian |
Director |
RSU Award |
60,600 |
- |
- |
60,600 |
| 2025-10-06 |
Chuang Emil |
Director |
RSU Award |
60,600 |
- |
- |
60,600 |
| 2025-09-04 |
Williams Donald Allen |
Director |
RSU Award |
64,400 |
- |
- |
64,400 |
| 2025-09-04 |
Wei Binxian |
Director |
RSU Award |
18,800 |
- |
- |
18,800 |
| 2025-09-04 |
Finley John David |
CEO, CFO |
RSU Award |
323,400 |
- |
- |
323,400 |
| 2025-09-04 |
Chuang Emil |
Director |
RSU Award |
18,800 |
- |
- |
18,800 |
| 2025-09-04 |
Jones Mitchell Lawrence |
Chief Medical Officer |
RSU Award |
289,000 |
- |
- |
289,000 |
| 2025-07-07 |
Chuang Emil |
Director |
Unknown |
- |
- |
- |
- |
| 2025-02-11 |
Finley John David |
CEO, CFO |
RSU Award |
40,000 |
- |
- |
40,000 |
| 2025-02-11 |
Jones Mitchell Lawrence |
Chief Medical Officer |
RSU Award |
24,000 |
- |
- |
24,000 |
| 2024-11-21 |
Williams Donald Allen |
Director |
Option Exercise |
388 |
- |
- |
728 |
| 2024-11-21 |
Wei Binxian |
Director |
Option Exercise |
388 |
- |
- |
855 |
| 2024-07-11 |
Williams Donald Allen |
Director |
RSU Award |
2,100 |
$4.49 |
$9.43K |
2,100 |
| 2024-07-11 |
Fischbein Margery B. |
Director |
RSU Award |
2,100 |
$4.49 |
$9.43K |
2,100 |
| 2024-07-11 |
Wei Binxian |
Director |
RSU Award |
2,100 |
$4.49 |
$9.43K |
2,100 |
| 2024-06-11 |
Williams Donald Allen |
Director |
Option Exercise |
340 |
- |
- |
340 |
| 2024-06-11 |
Wei Binxian |
Director |
Option Exercise |
465 |
- |
- |
467 |
| 2024-05-28 |
Williams Donald Allen |
Director |
Informative Buy |
1,000 |
$4.86 |
$4.86K |
1,000 |
| 2024-05-28 |
Finley John David |
CEO, CFO, Director |
Option Exercise (Sell) |
2,111 |
- |
- |
- |
| 2024-05-28 |
Jones Mitchell Lawrence |
Chief Medical Officer |
Option Exercise (Sell) |
1,555 |
- |
- |
- |
| 2024-05-24 |
Finley John David |
CEO, CFO, Director |
Informative Buy |
1,000 |
$4.81 |
$4.81K |
8,437 |
| 2024-05-20 |
Finley John David |
CEO, CFO, Director |
RSU Award |
666 |
$4.97 |
$3.31K |
7,437 |
| 2024-05-07 |
Fischbein Margery B. |
Director |
Disposition |
1,000 |
$7.90 |
$7.9K |
- |
| 2024-05-06 |
Finley John David |
CEO, CFO, Director |
Option Exercise (Sell) |
232 |
- |
- |
1,622 |
| 2024-05-06 |
Jones Mitchell Lawrence |
CEO, CFO, Director |
Tax Withholding of RSU |
90 |
$8.46 |
$761.40 |
724 |
| 2024-03-11 |
Finley John David |
CEO, CFO, Director |
Option Exercise (Sell) |
5,558 |
- |
- |
50,025 |
| 2024-02-09 |
Neal James R |
Director |
Option Exercise (Sell) |
12,160 |
$1.60 |
$19.46K |
- |
| 2024-02-08 |
Csimma Cristina |
Director |
Option Exercise (Sell) |
6,880 |
$0.59 |
$4.06K |
- |
| 2024-02-08 |
Trenschel Robert J. |
Director |
Option Exercise (Sell) |
6,880 |
$0.59 |
$4.06K |
- |
| 2024-02-08 |
Diaz Stephanie |
Director |
Option Exercise (Sell) |
6,880 |
$0.59 |
$4.06K |
- |
| 2024-02-06 |
Finley John David |
CEO, CFO, Director |
Informative Buy |
10,000 |
$0.47 |
$4.69K |
84,649 |
| 2024-02-06 |
Finley John David |
CEO, CFO, Director |
Option Exercise (Sell) |
3,475 |
- |
- |
27,800 |
| 2024-02-06 |
Jones Mitchell Lawrence |
Chief Medical Officer |
Option Exercise |
4,558 |
- |
- |
7,482 |
| 2024-01-31 |
Williams Donald Allen |
Director |
Informative Buy |
10,000 |
$0.61 |
$6.05K |
30,000 |
| 2024-01-31 |
Finley John David |
CEO, CFO, Director |
Informative Buy |
10,000 |
$0.56 |
$5.59K |
74,649 |
| 2024-01-03 |
Finley John David |
CEO, CFO, Director |
Option Exercise (Sell) |
1,309 |
- |
- |
- |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
